Breadcrumb

Santen facts and figures

€1.75 billion

€1.75 billion revenue (FY 2017) (approximately 224.9 billion yen) 

92% of revenue from prescription ophthalmic pharmaceuticals

92% of revenue from prescription ophthalmic pharmaceuticals

Overseas sales accounts for 29.5%

Overseas sales accounts for 29.5% of corporate revenue (FY 2017)

#1 in Japanese prescription ophthalmic pharmaceuticals

#1 in Japanese prescription ophthalmic pharmaceuticals 

Over 3,600 employees globally

Over 3,600 employees globally

Dedicated facility for ongoing research and development

Dedicated facilities for ongoing research and development: Nara Research and Development Centre, (Japan),  Evry (France), Emeryville (US)

Products supplied in  over 55 countries

Products supplied in over 55 countries

Four manufacturing sites

Four manufacturing sites: Noto and Shiga (Japan), Suzhou (China), Tampere (Finland)